Hepatic MyD88 regulates liver inflammation by altering synthesis of oxysterols
Open Access
- 1 July 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 317 (1) , E99-E108
Abstract
This study aimed to investigate the function of hepatic myeloid differentiation primary response gene 88 (MyD88), a central adaptor of innate immunity, in metabolism. Although its role in inflammation is well known, we have recently discovered that MyD88 can also mediate energy, lipid, and glucose metabolism. More precisely, we have reported that mice harboring hepatocyte-specific deletion of MyD88 (Myd88ΔHep) were predisposed to glucose intolerance, liver fat accumulation, and inflammation. However, the molecular events explaining the onset of hepatic disorders and inflammation remain to be elucidated. To investigate the molecular mechanism, Myd88ΔHepand wild-type (WT) mice were challenged by two complementary approaches affecting liver lipid metabolism and immunity. The first approach consisted of a short-term exposure to high-fat diet (HFD), whereas the second was an acute LPS injection. We discovered that upon 3 days of HFD Myd88ΔHepmice displayed an increase in liver weight and liver lipids compared with WT mice. Moreover, we found that bile acid and oxysterol metabolism were deeply affected by the absence of hepatic MyD88. Our data suggest that the negative feedback loop suppressing bile acid synthesis was impaired (i.e., ERK activity was decreased) in Myd88ΔHepmice. Finally, the predisposition to inflammation sensitivity displayed by Myd88ΔHepmice may be caused by the accumulation of 25-hydroxycholesterol, an oxysterol linked to inflammatory response and metabolic disorders. This study highlights the importance of MyD88 on both liver fat accumulation and cholesterol-derived bioactive lipid synthesis. These are two key features associated with metabolic syndrome. Therefore, investigating the regulation of hepatic MyD88 could lead to discovery of new therapeutic targets.Keywords
Funding Information
- Fonds De La Recherche Scientifique - FNRS (Belgian National Fund for Scientific Research) (FRFS-WELBIO WELBIO-CR-2017-C02, The Excellence Of Science : EOS 30770923)
- Funds Baillet Latour (Grant for Medical Research 2015))
- EC | European Research Council (ERC) (ERC Starting Grant 2013)
This publication has 26 references indexed in Scilit:
- 25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferonScience, 2014
- 25-Hydroxycholesterol acts as an amplifier of inflammatory signalingProceedings of the National Academy of Sciences, 2014
- The history of Toll-like receptors — redefining innate immunityNature Reviews Immunology, 2013
- On the formation and possible biological role of 25-hydroxycholesterolBiochimie, 2013
- 25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cellsRespiratory Research, 2012
- Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice, 2010
- Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharideJournal of Lipid Research, 2009
- 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A productionProceedings of the National Academy of Sciences, 2009
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasisCell Metabolism, 2005
- The Enzymes, Regulation, and Genetics of Bile Acid SynthesisAnnual Review of Biochemistry, 2003